0001493152-21-023101.txt : 20210920 0001493152-21-023101.hdr.sgml : 20210920 20210920083022 ACCESSION NUMBER: 0001493152-21-023101 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210914 FILED AS OF DATE: 20210920 DATE AS OF CHANGE: 20210920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AJJARAPU SURENDRA K CENTRAL INDEX KEY: 0001368298 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40793 FILM NUMBER: 211262107 MAIL ADDRESS: STREET 1: 8604 BUTTON BUSH CT CITY: TAMPA STATE: FL ZIP: 33647 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aesther Healthcare Acquisition Corp. CENTRAL INDEX KEY: 0001869974 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 871309280 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 515 MADISON AVE SUITE 8078 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (646) 908-2658 MAIL ADDRESS: STREET 1: 515 MADISON AVE SUITE 8078 CITY: NEW YORK STATE: NY ZIP: 10022 3 1 ownership.xml X0206 3 2021-09-14 0 0001869974 Aesther Healthcare Acquisition Corp. AEHA 0001368298 AJJARAPU SURENDRA K 515 MADISON AVENUE, SUITE 8078 NEW YORK NY 10022 1 1 1 0 Chief Executive Officer Class B common stock Class A common stock 2875000 I See footnote As described in the issuer's registration statement on Form S-1 (File No. 333- 258012) under the heading "Description of Securities," the shares of Class B common stock of the issuer will automatically convert into shares of Class A common stock of the issuer at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date. These shares represent 2,875,000 shares of Class B common stock of the issuer held by Aesther Healthcare Sponsor, LLC (the "Sponsor"), including an aggregate of up to 375,000 shares subject to forfeiture by the Sponsor to the extent that the underwriter's over-allotment is not exercised in full or in part (provided that a portion of such over-allotment has already been exercised and as such only 250,000 shares remain subject to forfeiture). Suren Ajjarapu is the managing member of the Sponsor and Chief Executive Officer of the Issuer. As such, the Reporting Person may be deemed to have beneficial ownership of such shares. Mr. Ajjarapu disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. /s/ Suren Ajjarapu 2021-09-17